Ignite Creation Date:
2024-05-06 @ 12:43 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03839823
Status:
COMPLETED
Last Update Posted:
2023-06-26
First Post:
2019-01-24
Brief Title:
Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-24
First Submit QC Date:
February 11 2019
Study First Post Date:
2019-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2023-06-26
Last Update Post Date Type:
ACTUAL